Saltar al contenido
Merck

Synthesis and enzymatic evaluation of novel partially fluorinated thiol dual ACE/NEP inhibitors.

Bioorganic & medicinal chemistry letters (2009-07-15)
Francesca Olimpieri, Simone Tambaro, Santos Fustero, Paolo Lazzari, Maria Sanchez-Roselló, Luca Pani, Alessandro Volonterio, Matteo Zanda
RESUMEN

A novel family of peptidomimetics incorporating fluoroalkyl groups, mainly a trifluoromethyl, in alpha-position to a zinc(II)-binding thiol function, was synthesized in solution as well as in solid-phase. These compounds showed inhibitory potency in the nanomolar range against both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP), whereas no inhibition of endothelin-converting enzyme-1 (ECE-1) was observed. The trifluoromethyl-derivatives were more potent than the parent unfluorinated analogues in the case of ACE, and less potent in the case of NEP.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Captopril, ≥98% (HPLC), powder
Sigma-Aldrich
DL-Thiorphan, ≥98% (TLC)
Sigma-Aldrich
Captopril, meets USP testing specifications